These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3491315)

  • 1. Hemophilus influenzae type B disease in children vaccinated with type B polysaccharide vaccine.
    Granoff DM; Shackelford PG; Suarez BK; Nahm MH; Cates KL; Murphy TV; Karasic R; Osterholm MT; Pandey JP; Daum RS
    N Engl J Med; 1986 Dec; 315(25):1584-90. PubMed ID: 3491315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired antibody response to Haemophilus influenzae type b polysaccharide and low IgG2 and IgG4 concentrations in Apache children.
    Siber GR; Santosham M; Reid GR; Thompson C; Almeido-Hill J; Morell A; deLange G; Ketcham JK; Callahan EH
    N Engl J Med; 1990 Nov; 323(20):1387-92. PubMed ID: 2233905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
    Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
    N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro induction of IgG1 and IgG2 secretion by B cells of children who developed invasive haemophilus disease despite vaccination.
    Chacko A; Granoff DM
    Pediatr Res; 1991 Jul; 30(1):124-9. PubMed ID: 1891277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of Hemophilus influenzae type b bacteremic infections with the capsular polysaccharide vaccine.
    Peltola H; Käyhty H; Virtanen M; Mäkelä PH
    N Engl J Med; 1984 Jun; 310(24):1561-6. PubMed ID: 6610125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective efficacy of Haemophilus influenzae type b polysaccharide vaccine.
    Shapiro ED; Berg AT
    Pediatrics; 1990 Apr; 85(4 Pt 2):643-7. PubMed ID: 2179854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemophilus influenzae type b capsular polysaccharide vaccine in children: a double-blind field study of 100,000 vaccinees 3 months to 5 years of age in Finland.
    Peltola H; Käyhty H; Sivonen A; Mäkelä H
    Pediatrics; 1977 Nov; 60(5):730-7. PubMed ID: 335348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency.
    Umetsu DT; Ambrosino DM; Quinti I; Siber GR; Geha RS
    N Engl J Med; 1985 Nov; 313(20):1247-51. PubMed ID: 3877240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of Haemophilus b conjugate vaccine (meningococcal protein conjugate) in children with prior invasive Haemophilus influenzae type b disease.
    Walter EB; Moggio MV; Drucker RP; Wilfert CM
    Pediatr Infect Dis J; 1990 Sep; 9(9):632-5. PubMed ID: 2235187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG subclass response to immunization with Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine.
    Granoff DM; Weinberg GA; Shackelford PG
    Pediatr Res; 1988 Aug; 24(2):180-5. PubMed ID: 3263612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum antibodies after vaccination with Haemophilus influenzae type b capsular polysaccharide and responses to reimmunization: no evidence of immunologic tolerance or memory.
    Käyhty H; Karanko V; Peltola H; Mäkelä PH
    Pediatrics; 1984 Nov; 74(5):857-65. PubMed ID: 6387614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
    Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM
    JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
    Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with Haemophilus influenzae type b conjugate vaccines.
    Mäkelä PH; Eskola J; Peltola H; Takala AK; Käyhty H
    Pediatrics; 1990 Apr; 85(4 Pt 2):651-3. PubMed ID: 2179855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further immunologic evaluation of children who develop haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
    Granoff DM; Sheetz KE; Nahm MH; Madassery JV; Shackelford PG
    Monogr Allergy; 1988; 23():256-68. PubMed ID: 3260336
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunogenicity of Haemophilus influenzae type b polysaccharide-outer membrane protein conjugate vaccine in patients who acquired Haemophilus disease despite previous vaccination with type b polysaccharide vaccine.
    Granoff DM; Chacko A; Lottenbach KR; Sheetz KE
    J Pediatr; 1989 Jun; 114(6):925-33. PubMed ID: 2786062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization of children with sickle cell disease with Haemophilus influenzae type b polysaccharide vaccine.
    Rubin LG; Voulalas D; Carmody L
    Pediatrics; 1989 Sep; 84(3):509-13. PubMed ID: 2788866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with Haemophilus influenzae type b polysaccharide vaccine at 18 and 24 months of age: evidence of decreased immunogenicity.
    Adderson EE; Chisholm N; Halperin SA
    Clin Invest Med; 1991 Aug; 14(4):338-45. PubMed ID: 1782732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.